India's Supreme Court bars Glenmark from selling copies of Merck diabetes drugs: sources

[May 15, 2015]  MUMBAI (Reuters) - India's Supreme Court has blocked Glenmark Pharmaceuticals Ltd from selling copies of U.S. drugmaker Merck & Co Inc's diabetes drugs Januvia and Janumet, sources with knowledge of the matter said after a court hearing on Friday.

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

Merck sued Glenmark in 2013 for infringing a patent it has on sitagliptin, the chemical compound in Januvia and Janumet. Glenmark sells the medicines under the brand names Zita and Zita-met.

(Reporting by Zeba Siddiqui and Nivedita Bhattacharjee in Mumbai)
 

[© 2015 Thomson Reuters. All rights reserved.]

Copyright 2015 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.